Company intelligence / Profile preview

iLoF

London, England, United Kingdomilof.tech ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

The iLoF platform has demonstrated significant reductions in time and cost for patient screening in clinical trials—up to a 70% reduction in screening time and up to a 40% reduction in costs. It enables non-invasive stratification of patients using optical fingerprints from blood-derived samples. The company has ongoing pilots with pharmaceutical companies and academic centers focused on Alzheimer’s disease, ovarian cancer, COVID‑19 outcomes prediction, among others. No direct drug candidates are being developed by the company itself.

Therapeutic areas: OtherOncologyNeurologyInfectious Diseases
Modalities: Device (proprietary multispectral sensor)Non-pharmacological therapy (screening/stratification tool)Digital biomarker platform
Industry: Digital Health Medical Devices

Partnerships

Multiple global pharmaceutical companies engaged as pilot users or collaboratorsAcademic collaborations include University of Rochester and Rochester Institute of Technology

Beyond the preview

Go deeper on iLoF.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iLoF.

Explore the full profile